A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors
Clinical trial NCT02622321 · COMPLETED
Trial details
- NCT number
- NCT02622321
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-18
- Primary completion
- 2016-10-25
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.